logo
icon

Join as a Volunteer

From scientific discovery to meaningful impact

The MARC Bioscience Research Laboratories are a leading provider of integrated basic and translational research, equipped with advanced technologies and a multidisciplinary team dedicated to transforming scientific discoveries into real-world solutions.

Our Laboratory Capabilities

State-of-the-art units, advanced technologies, and expert teams working together to accelerate scientific discovery and real-world impact.

Biorepository Unit

Research Topics 1 Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Learn more

Molecular Biology Unit

Research Topics Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Learn more

Bioinformatics Unit

Research Topics Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Learn more

Genomics Unit

Research Topics 2 Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Learn more

Molecular Biology Unit 2

Research Topics Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Learn more

Our Services & Solutions

Specialized research services tailored to your project needs, from sample collection to advanced analysis.
Biorepository & Biospecimen Services
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Sequencing Service
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Nanotechnology & Nanoformulation Service
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Immunology Research Services
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Bioinformatics Unit
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Molecular Biology Services
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Cell Culture & Cellular Assays
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)

What We Work On

We drive innovation through strategic research projects and grants, focusing on key areas in bioscience and translational research that address real-world healthcare challenges.
Bioinformatics
Contract Research Organization
Medical Writing and Data management
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Genomics
Contract Research Organization
Medical Writing and Data management
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Molecular Biology
Contract Research Organization
Medical Writing and Data management
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
Cell Culture
Contract Research Organization
Medical Writing and Data management
Study subjects will receive one dose of study intervention as assigned at each vaccination visit (Visits 1 and 4) via intramuscular (IM) injection in the upper arm approximately 14 days apart. Study interventions should be administered into the deltoid muscle, preferably of the nondominant arm . Each subject will be assigned to receive either: - 35 mcg dose for both vaccinations at day 0 and day 14 (low dose, 15 subjects) - 70 mcg dose for both vaccinations at day 0 and day 14 (high dose, 15 subjects) - Placebo for both injections at day 0 and day 14 (Placebo, 15 subjects)
marc-logo
A newly established integrative research center that aims to advance science by conducting research into interdisciplinary disease areas
Subscribe for our latest news and updates
Follow Us
facebook
linkedin
Get our latest updates and news
About MARC
MARC Solutions
Network
Newsroom
Reference Material
© 2022 MARC - All Rights Reserved